Repare Therapeutics

Repare Therapeutics

Repare Therapeutics

Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells.
Raised
$68M
Follow us
Alexa global traffic share
Twitter followers
22 Jun 2017
$68,000,000
Venture capital (Series A)

Quebec's Repare Therapeutics raises $68M in Series A funding

Funding Report
+1